Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience
Görner M, Brasch F, Hirnle P, Gehl H-B, Scholtz L-U, Wegehenkel K, Sudhoff H (2013)
European Journal of Cancer Care 22(5): 648-652.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Görner, M.;
Brasch, F.;
Hirnle, P.;
Gehl, H.-B.;
Scholtz, L.-U.;
Wegehenkel, K.;
Sudhoff, HolgerUniBi 
Erscheinungsjahr
2013
Zeitschriftentitel
European Journal of Cancer Care
Band
22
Ausgabe
5
Seite(n)
648-652
ISSN
0961-5423
Page URI
https://pub.uni-bielefeld.de/record/2951882
Zitieren
Görner M, Brasch F, Hirnle P, et al. Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience. European Journal of Cancer Care. 2013;22(5):648-652.
Görner, M., Brasch, F., Hirnle, P., Gehl, H. - B., Scholtz, L. - U., Wegehenkel, K., & Sudhoff, H. (2013). Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience. European Journal of Cancer Care, 22(5), 648-652. https://doi.org/10.1111/ecc.12070
Görner, M., Brasch, F., Hirnle, P., Gehl, H.-B., Scholtz, L.-U., Wegehenkel, K., and Sudhoff, Holger. 2013. “Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience”. European Journal of Cancer Care 22 (5): 648-652.
Görner, M., Brasch, F., Hirnle, P., Gehl, H. - B., Scholtz, L. - U., Wegehenkel, K., and Sudhoff, H. (2013). Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience. European Journal of Cancer Care 22, 648-652.
Görner, M., et al., 2013. Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience. European Journal of Cancer Care, 22(5), p 648-652.
M. Görner, et al., “Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience”, European Journal of Cancer Care, vol. 22, 2013, pp. 648-652.
Görner, M., Brasch, F., Hirnle, P., Gehl, H.-B., Scholtz, L.-U., Wegehenkel, K., Sudhoff, H.: Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience. European Journal of Cancer Care. 22, 648-652 (2013).
Görner, M., Brasch, F., Hirnle, P., Gehl, H.-B., Scholtz, L.-U., Wegehenkel, K., and Sudhoff, Holger. “Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas - a single institution experience”. European Journal of Cancer Care 22.5 (2013): 648-652.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 23701280
PubMed | Europe PMC
Suchen in
Google Scholar